Alerts

At the time of writing, the TGA has been advised that approximately 9,054 PIP breast implants have been implanted by surgeons between 2002 and 2010. In April 2010 non-implanted PIP breast implants were recalled from the Australian marketplace.

Updated recommendations for Pneumovax 23 revaccination due to high rates of local reactions after repeat doses.

We are updating safety information for Simvastatin due to new contraindications, precautions, and dosage recommendations. Consult your doctor if you have concerns.

Specific lots of an additional contact lens model i.e. Avaira Sphere Contact Lens have been identified as being affected by the unintended presence of a residue identified as silicone oil.

Specific packs (lots) of Avaira Sphere contact lenses are being recalled by CooperVision Australia Pty Ltd

We are recalling all batches of Savacol Antiseptic Mouth & Throat Rinse (alcohol-free) due to bacterial contamination.

Xigris (drotrecogin alfa) is being withdrawn from the market because it does not improve survival rates in severe sepsis patients. Stop using it and consult your doctor for alternative treatments.

The Therapeutic Goods Administration (TGA) has been advised by Ferno Australia Pty Ltd that a small number of Meducore Easy Automatic External Defibrillator (AEDs) that are currently being recalled for product correction cannot be located.

The TGA has become aware that the EIUS unicompartmental1 knee prosthesis supplied by Stryker Australia has a higher than expected revision rate (rate of revision surgery). Supply of the product in Australia has been suspended.

This is an update to the alert issued by the TGA on 16 June 2011. Johnson and Johnson have advised the TGA of additional serial numbers affected by the recall.